Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FZ94F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,612
Award facts
- Contract value 100% obligated
- $11,612.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,612.37 to AmerisourceBergen Drug Corp for the supply of Vraylar 1.5 mg capsules (30-count units) on December 10, 2025, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement valued through December 2026 that provides comprehensive pharmaceutical support for military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across defense and civilian healthcare systems. Through its DLA prime vendor contract, the company supplies an extensive portfolio of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for Vraylar, a neurological treatment medication, exemplifies the company's role in fulfilling routine pharmaceutical needs within the broader defense medical supply chain that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FZ94F?
SPE2DR26FZ94F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FZ94F worth?
The government has obligated $11,612 on SPE2DR26FZ94F.
Is contract SPE2DR26FZ94F an order under another contract?
Yes. SPE2DR26FZ94F is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FZ94F competed?
The extent of competition for SPE2DR26FZ94F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award